Trade Citius Pharmaceuticals, Inc. - CTXR CFD

Trading Conditions

• Type: CFD
• Spread: 0.0209
• Long position overnight funding adjustment: -0.02157%
• Short position overnight funding adjustment: -0.00065%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 10
• Margin: 5.00%
• Stock exchange: United States of America
• Commission on trade: 0%
• Guaranteed stop premium: 1%

Key Stats

• Prev. Close: 0.8602
• Open: 0.8747
• 1-Year Change: -44.59%
• Day's Range: 0.8747 - 1.0178

What is Citius Pharmaceuticals, Inc. (CTXR)?

Citius Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of therapeutic products primarily in the fields of oncology, infectious diseases, and critical care. The company develops proprietary drug candidates and reformulations intended to address unmet medical needs. Its pipeline includes products designed to improve treatment outcomes through novel delivery methods and enhanced efficacy. Citius Pharmaceuticals also engages in licensing and acquisition activities to expand its portfolio. The company operates within the pharmaceutical sector, emphasizing clinical development and regulatory approval processes to bring new therapies to market.

Citius Pharmaceuticals, Inc. Stock Price Today: Live Overview

The price today is shaped by current trade activity with Citius Pharmaceuticals, Inc. valued at $0.9709. Throughout the session, the price moved from $0.8578 up to $1.0178, with an overall change of 0%.

FAQ: Citius Pharmaceuticals, Inc. (CTXR)

What is the current price of CTXR stock?

Citius Pharmaceuticals, Inc. shares are priced at $0.9709 currently.

Does CTXR pay dividends?

Citius Pharmaceuticals, Inc. does not distribute dividends to shareholders.

Does CTXR have a formal corporate presence or regional headquarters in the UAE?

Citius Pharmaceuticals, Inc. does not have a direct presence in the UAE and operates via local partners only.

What is CTXR best known for?

Citius Pharmaceuticals, Inc. is most famous for its development of therapeutic products focusing on acute care.

What assets are typically shown together with CTXR?

Commonly shown alongside CTXR: Hafnia Ltd, Lisata Therapeutics, Inc, Universal Corp